AI Insight
Psoriasis is a chronic immune-mediated skin disease affecting over 40 million people globally, characterized by inflammatory manifestations in both skin and musculoskeletal systems. The condition exists on a spectrum that includes psoriatic arthritis, with multiple clinical presentations ranging from chronic plaque psoriasis to guttate, palmoplantar, erythrodermic, and pustular forms. These varied manifestations share common genetic, environmental, and immunological drivers.
Why it matters
Understanding psoriasis as a systemic disease spectrum rather than isolated skin condition enables more comprehensive treatment approaches that address both dermatological and joint symptoms. The identification of shared immunological mechanisms across different psoriatic manifestations may guide development of targeted therapies benefiting millions of affected individuals worldwide.
Understand the Science
Psoriasis is a common, chronic, immune-mediated skin disease affecting more than 40 million individuals worldwide. Psoriasis, along with psoriatic arthritis, are part of a broader psoriatic disease spectrum, and present with inflammatory skin and musculoskeletal manifestations driven by shared genetic, environmental, and immunological mechanisms. Skin psoriasis presents with diverse clinical phenotypes, including chronic plaque psoriasis, guttate, palmoplantar, erythrodermic, and pustular forms.
Source: [Seminar] Psoriasis